The golf clubs, the pedometer and the pharma press release all showed up at once. DJ Khaled weight loss is the story of the week: he says he has lost 75 pounds, about a quarter of his body weight, in a year on Wegovy. Now he is the paid face of a campaign built around it. Nobody is hiding the commercial angle, and neither will I.
Here is the setup. Novo Nordisk announced the partnership on PR Newswire on Nov. 12. The campaign, called “Walk, Golf, and Wegovy,” follows his diet and exercise routine. Khaled has taken the drug, whose active ingredient is semaglutide, since late 2025.

What Khaled said about his Wegovy results
In the company’s release, Khaled said he has been on Wegovy for a year. “I’m sharing more of my routine and the consistency that’s getting results,” he said. He added that he lost 75 pounds, “or about 25% of my body weight.”
The release itself labels that result “his personal experience.” That is a fair label. The number is self-reported, and it appears inside a manufacturer promotion. Neither side has disclosed the payment terms. We found no independent medical verification.
He also told E! News that he now gets “more than 10,000 steps in a day.” His goal at the start, he said, was simply to hit his daily pedometer max. His doctor, he added, “loved the idea” of Wegovy.
The DJ Khaled 75 pounds figure depends on who is counting
Novo, E! and Yahoo all say 75 pounds. Men’s Journal, citing People, puts it closer to 90 pounds, from a start near 295 or 300. We did not review the People original. So 75 is the official figure here, and the gap stays flagged.
Earlier coverage showed smaller totals along the way. Those read as snapshots from a journey in progress, not errors. In 2023, E! reported he had gone from 293 pounds to 263 through golf. His weight was already a story back then.
Here’s the thing: this Khaled GLP-1 pitch is an ad, and it’s a loud one
Here’s the thing: if you are thinking about a drug like this, a famous face is not a medical opinion. Khaled is far from the first celebrity to front a GLP-1 drug. The campaign aims to get people talking to their doctors about Wegovy. That is a legitimate goal. Still, it is marketing, and a famous face is the most effective kind.
So read his result for what it is: one man’s experience, on a drug that works alongside a diet and exercise plan. Doctors prescribe Wegovy with a reduced-calorie diet and more activity. It is meant for adults with obesity, or excess weight plus related health problems. Researchers are also exploring what the evidence shows about benefits beyond weight loss, but that is a separate question from one celebrity’s results.
How does his result compare to the trial numbers? In a 68-week study of 1,961 adults, Wegovy 2.4 mg produced an average weight loss of 15%. That is roughly 35 pounds from a 232-pound start. The placebo group lost about 2.5%.
A 25% loss is well above that average, and the company is not presenting it as typical.
Risks matter too. Regulators recently added a vision loss warning to GLP-1 drugs, so the full picture includes more than a before-and-after photo.
What happens next for the DJ Khaled transformation
Khaled will keep sharing his progress and routine with fans as part of the campaign. Novo has announced no dates. His stated target, per People via Men’s Journal, is about 200 pounds: “I would love to get to 200 pounds.”
He told Yahoo he is at his goal weight because he is more flexible and can move. For a 50-year-old with two young sons, that may be the most persuasive part of the pitch. It is also the part no press release can verify.
If you are curious where the field is heading, see how Lilly’s retatrutide stacks up against Ozempic.
And if you are weighing Wegovy or any similar drug, the real answer is a boring one: ask your doctor, not the guy with the golf clubs.






